VANCOUVER, British Columbia, July 23, 2019 /PRNewswire/ -- Lifestyle Delivery Systems Inc. (CSE: LDS), (OTCQX: LDSYF), (Frankfurt: LD6, WKN: A14XHT) ("LDS" or the "Company") announces 10 additional dispensaries as CSPA Group, Inc., the Company's wholly-owned subsidiary, continues to expand the availability of its flagship product, CannaStrips™, within the California market.
CannaStrips™ availability continues to grow as planned and the positive consumer feedback is great to hear as the Company gains additional exposure in the recreational market throughout California. The Company continues to identify industry influencers and potential collaborative partners to realize the market potential of its discreet and effective CannaStrips™.
CSPA's team holds vendor days, trains retailers, and educates budtenders about the vast advantages that CannaStrips™ have over anything else on the store shelf. Casey Fenwick, the President of LDS, stated, "We are seeing the benefits of our customer focussed approach as the educated retailers and customers recommend our product thereby increasing sales and the speed of reorders. The affordability of CannaStrips™ immediately removes any consumer purchase apprehension and encourages traditional cannabis consumers to explore a new product and realize the social benefits of adding CannaStrips™ to their cannabis use. Continuing to gain market awareness is hugely beneficial as we approach critical mass and full market acceptance of CannaStrips™. The feedback from consumers is very positive on efficacy, ease of use, discretion and ability to use the product in nearly any social setting."
Below are 10 new dispensaries carrying CannaStrips™: Patient Care First Phenos Doctors Choice Silverstreak Delivery Honest Choice The Higher Conscience The Peoples Remedy (McHenry) LA Kush Safe Capitol Compassion Co-Op LPC Delivery
About CSPA Group Inc.
CSPA Group, Inc. is located in Adelanto, California and is a City-Permitted and State-Licensed manufacturer and distributor/transporter in the California cannabis industry. CSPA Group manufactures extracted oils and distillates, and producing CannaStrips™ under a license agreement with Lifestyle Delivery Systems Inc., a British Columbia corporation.
CannaStrips™ is formulated oral strip for effective buccal mucosal delivery that disrupts the barrier created by saliva coating the mucosal membrane for the active materials (in this case cannabinoids) which have been nanoparticulated and encapsulated to penetrate the multiple layers of mucosal and sub-mucosal membranes to the blood stream. Once in the blood stream the encapsulation is undetectable as a foreign material by the liver. This undetectability allows the material to avoid being filtered out of the blood stream by the liver. The encapsulation also is more effective in penetrating the blood-brain barrier and allowing for greater bioavailability and extending the effective time from a single dose.
About Lifestyle Delivery Systems Inc.
Lifestyle Delivery Systems Inc. is a technology company that licenses its technology to a state-of-the-art production and packaging facility located in Southern California. The Company's technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to other forms of delivery but also superior bioavailability of cannabis constituents. Some strips will also include supplemental co-active ingredients such as nutraceuticals, vitamins and peptides. The technology provides a new way to accurately meter the dosage and assure the purity of selected product. From start to finish, the production process, based on the Company's technology, tests for quality and composition of all the ingredients used in each and every strip which results in a delivery system that is safe, consistent and effective.
Lifestyle Delivery Systems Inc. Brad Eckenweiler CEO & Director
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control. Such factors include, among other things: risks and uncertainties relating to the Company's limited operating history and the need to comply with environmental and governmental regulations. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970. Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, The Company undertakes no obligation to publicly update or revise forward-looking information.